Lisaftoclax Plus Azacitidine Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients at High Risk of Relapse
Clinical trial NCT07686965 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07686965
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-10
- Primary completion
- 2030-08-10
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.